Biogen reported $1.92B in Operating Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 8821M 991M
Acadia Pharmaceuticals ACAD:US $ 228.48M 53.07M
Acorda Therapeutics ACOR:US $ 39.24M 9.29M
ALKERMES ALKS:US 305.13M 16.95M
Amgen AMGN:US $ 3.74B 804M
Bayer BAYN:GR 10.43B 1.33B
Biogen BIIB:US $ 1921.1M 225.6M
Biomarin Pharmaceutical BMRN:US $ 382.03M 133.66M
Bluebird Bio BLUE:US $ 122.29M 14.98M
Bristol Myers Squibb BMY:US $ 9.1B 247M
Eli Lilly And LLY:US $ 5405.7M 677M
Esperion Therapeutics ESPR:US $ 61.82M 9.2M
Gilead Sciences GILD:US $ 6393M 89M
Intercept Pharmaceuticals ICPT:US $ 98.85M 14.42M
Intra Cellular Therapies ITCI:US $ 107.66M 4.02M
Marinus Pharmaceuticals MRNS:US $ 30.9M 2.26M
Merk MRK:US $ 10332M 386M
Moderna Inc MRNA:US 1.84B 38M
Neurocrine Biosciences NBIX:US $ 307.5M 40.8M
Novartis NOVN:VX 9.96B 998M
Pfizer PFE:US $ 15788M 3271M
Ptc Therapeutics PTCT:US $ 235.26M 14.7M
Puma Biotechnology PBYI:US $ 46.5M 1.83M
Regeneron Pharmaceuticals REGN:US $ 1706.6M 605.4M
Sangamo Biosciences SGMO:US $ 73.49M 5.61M
Sarepta Therapeutics SRPT:US $ 297.71M 9.56M
Seattle Genetics SGEN:US $ 559.51M 42.41M
Teva Pharmaceutical TEVA:IT 4.37B 352M
Ultragenyx Pharmaceutical RARE:US $ 216.57M 30.61M
United Therapeutics UTHR:US $ 175.6M 69.8M
Vertex Pharmaceuticals VRTX:US $ 1056.6M 138.24M
YTE INCY:US $ 616.69M 135.42M